Open house drug discount agreements Opipramol, ATC N06AA05

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Feb 05, 2027 · 160 days left·Open·Supplies·Framework

Inscrivez-vous pour sauvegarder Open documents

Titre original de l'avis

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Opipramol, ATC N06AA05

45/100

Score d'opportunité

Needs reviewLow complexity

SuppliesFrameworkOpen

Pourquoi ce score ?

Opportunité

45 / 100

Complexité

20 / 100

Facteurs de risque

No minimum volume commitment. Revenue is uncertain and may be low if few patients use Opipramol or if other discount ag...

Automatic termination if a regional/national public-law discount contract for the same active ingredient takes effect...

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

Description
Industries & Services
Capabilities
Market & Experience
Certifications

Aperçu

Moderate opportunity

Faits clés

Framework procurement
Supplies contract
1 lot
Duration until Mar 2027
Provide discounts on Opipramol (ATC N06AA05) to AOK Bayern insured persons.
Non-exclusive; multiple suppliers can participate.

Afficher le résumé complet

This is an open-house model (not a traditional procurement) by AOK Bayern for non-exclusive discount agreements on the drug Opipramol (ATC N06AA05). All eligible pharmaceutical companies can join under identical non-negotiable terms. Contracts run from April 1, 2025 to March 31, 2027, with possible earlier termination if a competing regional or national discount contract takes effect.

Risques

No minimum volume commitment. Revenue is uncertain and may be low if few patients use Opipramol or if other discount ag...

Automatic termination if a regional/national public-law discount contract for the same active ingredient takes effect...

Exigences clés

Eligibility

Only pharmaceutical companies are eligible.

Administrative

Submit signed contract (in duplicate if paper) plus annex 'Festlegung der vertragsgegenständlichen Arzneimittel' and signed declaration of reliability.
Documents can be submitted either in paper form (hand-signed, 2 copies) or electronically with qualified electronic signature via the DTVP portal.

Acheteur

Nom

AOK Bayern - Die Gesundheitskasse

Localisation

München, DEU

[email protected]

Site web

www.aok.de

Profil acheteur

Ouvrir le profil

Identifiant

DE811695320

Activité

Health

Lots (1)

LOT-0001

Open house drug discount agreements Opipramol, ATC N06AA05

Non-exclusive discount agreements for Opipramol. No selection process; any eligible pharmaceutical company can sign the standard contract. Contract start: earliest 01.04.2025, end: 31.03.2027. Submission possible until 05.02.2027.

SuppliesFrameworkEU fundedElectronic submission

Localisation

DE212, Germany

Durée

Mar 2025 - Mar 2027

Catégorie

Pharmaceutical products

Date limite

Deadline Feb 05, 2027

Détails de la procédure

Date de publication: 17 Feb 2025
Langues: German

Métadonnées de référence

Base juridique: 32014L0024

Identifiants de référence

ID de l'appel d'offres: 108776-2025

Documents (2)

Document de consultation 1 Portail de soumission 1

Appels d'offres similaires

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3